Aeternum Health Reports No Revenue, Significant Asset Growth Following Merger

Aeternum Health, Inc. (formerly Shorepower Technologies Inc.) reported significant financial developments in its latest 10-Q filing for the quarter ending June 30, 2026. The company, which has transitioned from a focus on transportation electrification to healthcare and critical mineral mining, recorded no revenue from continuing operations during the period. Operating expenses totaled $270,879 for the three months ended June 30, 2026, reflecting costs associated with professional fees, exploration, and consulting services. This marks a notable shift from the previous year, where no operating expenses were reported for the same period.

The company’s financial position has improved markedly compared to the end of the previous fiscal year. As of June 30, 2026, Aeternum Health reported total assets of $1.93 million, a substantial increase from $54,557 at the end of December 2025. This growth is primarily attributed to a significant rise in cash reserves, which increased to $702,809 from $15,374. The company’s liabilities also rose slightly to $2.27 million, up from $2.05 million, largely due to increased notes payable to related parties.

Strategically, Aeternum Health has undergone a major transformation following its merger with Aeternum Health LLC, which was finalized on June 30, 2026. This merger has shifted the company’s focus towards healthcare solutions, particularly in longevity and anti-aging therapies, as well as critical mineral mining. The company has also established new subsidiaries in the Cayman Islands and South Africa to support its expanded operations. The merger included a commitment to issue shares representing 51% ownership to Paul Mann, the president of Aeternum Health LLC, and the company is expected to invest at least $1.5 million in assets related to its new business focus.

In terms of operational metrics, Aeternum Health has not yet generated revenue from its new business lines, and the company anticipates incurring additional costs as it develops its healthcare and mining initiatives. The company reported a net income of $1.72 million for the three months ended June 30, 2026, primarily due to a gain of $2.01 million from the disposal of its discontinued Shorepower business. This gain has allowed the company to offset losses from continuing operations, which totaled $270,879 for the quarter.

Looking ahead, Aeternum Health acknowledges the need for additional financing to support its ongoing operations and strategic initiatives. The company plans to pursue funding through a combination of debt and equity financing, as well as related-party loans. However, management has expressed uncertainty regarding the availability of such financing, which raises concerns about the company’s ability to continue as a going concern over the next year. The company’s future performance will depend on its ability to successfully execute its new business strategy and generate sufficient revenues from its healthcare and mining operations.